Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Long-Term Investments: 2021-2024

Historic Long-Term Investments for Mirum Pharmaceuticals (MIRM) over the last 2 years, with Dec 2024 value amounting to $12.5 million.

  • Mirum Pharmaceuticals' Long-Term Investments fell 73.50% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 73.50%. This contributed to the annual value of $12.5 million for FY2024, which is N/A change from last year.
  • Per Mirum Pharmaceuticals' latest filing, its Long-Term Investments stood at $12.5 million for FY2024, which was up 151.37% from $5.0 million recorded in FY2021.
  • Mirum Pharmaceuticals' 5-year Long-Term Investments high stood at $12.5 million for FY2024, and its period low was $5.0 million during FY2021.
  • Moreover, its 1-year median value for Long-Term Investments was $12.5 million (2024), whereas its average is $12.5 million.